NCT02183662View on ClinicalTrials.gov

Safety and Pharmacokinetics of Single Rising Oral Doses of BI 224436 ZW in Healthy Male Volunteers.

PHASE1CompletedINTERVENTIONAL
Enrollment

105

Participants

Timeline

Start Date

November 30, 2009

Primary Completion Date

March 31, 2010

Conditions
Healthy
Interventions
DRUG

BI 224436

DRUG

Placebo to BI 224436

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY